Skip to main content

Ophthalmic Drugs Market is Predicted to Register a Healthy CAGR of 5.1% During forecast to 2025

Market Overview:
Increased level of research in the market is expected to motivate the development of ophthalmic drugs. The expansion of the pharmaceutical sector is expected to motivate the market at an incremental rate in the coming years. Moreover, increased government backing is expected to encourage the progress of the ophthalmic drug market in the approaching years.
                        
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5753

Reports that review the pharmaceutical industry have been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities
Ophthalmic Drugs Market Forecast is expected to register 5.1% CAGR during the forecast period of 2019 to 2025 and held a market value of USD 29.46 Billion in 2018.
.

Competitive Analysis:
  • Valeant Pharmaceuticals International In
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Shire plc
  • Santen Pharmaceutical Co
  • Regeneron Pharmaceuticals Inc
  • Pfizer Inc
  • Merck & Co
  • Genentech Inc
  • Bausch & Lomb Inc
  • Allergan plc
  • Actavis Generics
Segmentation:
  • The global ophthalmic drugs market is segmented on the basis of indication, drug class, type of dosage, product, and distribution channel.
  • On the basis of indication, the market is classified as glaucoma, retinal disorders, inflammation/infection, dry eye, allergies, uveitis, and others.
  • On the basis of drug class, the market is classified as antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma, and others. The anti-inflammatory segment is further segmented into nonsteroidal drugs and steroidal drugs.
  • On the basis of type of dosage, the market is classified as eye drops, eye solutions, ointments, capsules and tablets, and gels.
  • On the basis of the product, the market is classified as prescription drugs and OTC drugs.
  • On the basis of the distribution channel, the market is classified as hospital pharmacies, online pharmacies, drug stores, and others.
Regional Analysis:
The Americas dominates the global ophthalmic drugs market and is likely to remain the leading regional market over the forecast period due to the rising prevalence of ophthalmic conditions and the high healthcare expenditure in the region. Glaucoma accounts for up to 10 million visits to the physician in the U.S., leading to considerable expenses and demand for drugs. More than 120,000 in the U.S. are blind because of glaucoma. These numbers are highly good news for the ophthalmic drugs market in the Americas. The growing patient population suffering from ophthalmic diseases is likely to drive the Americas market for ophthalmic drugs over the forecast period. North America is likely to remain the leading revenue generator in the global ophthalmic drugs market over the forecast period.

Europe is likely to hold on to the second place in the global ophthalmic drugs market over the forecast period due to a similar set of reasons. The growing patient population in Europe for ophthalmic diseases
Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more